Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

MYND Life Sciences (CSE: MYND) (OTC Pink: MYNDF) ("MYND" or the "Company") a clinical-stage life sciences company committed ...

Neumora Therapeutics Inc.’s stock tumbled 81% Thursday after the clinical-stage biotech said a late-stage trial of a treatment for major depressive disorder failed to meet its main goals.

A team of international researchers, including Australians, analysed data from 29 countries across the world and uncovered ...

Psilocybin from "magic mushrooms" has been found in studies to ease the depression and anxiety of individuals with cancer and ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

We've never been closer to accurately assessing whether an individual is more susceptible to developing major depressive ...

Did you know that spending 20 minutes in a hot sauna three times a week can be a highly effective treatment for depression?  Randomized clinical trials have dem ...

Intra-Cellular’s clinical-stage pipeline is promising, with pipeline agents under development for a wide range of neurological indications.

Major depressive disorder (MDD) is a leading cause of disability worldwide and unfortunately no treatment without side effects is available. Previous reports have found unbalanced glutamate-glutamine ...

Johnson & Johnson is starting the year off strong with a $14.6 billion acquisition of the biopharma firm Intra-Cellular Therapies — best known for its blockbuster drug Caplyta. The deal was announced ...

And GSK said it would pay up to $1.15 billion privately-held IDRx, a clinical-stage biopharmaceutical company developing therapeutics for the treatment of GIST, which stands for Gastrointestinal ...